The PFNT Facility is a coherent set of exploration tools in neurobiology allowing research at the molecular, cellular and integrated levels.
A successful partnership between the APHM Pathology department / the GlioME team and ID-Solutions industrial society (https://www.id-solutions.fr/fr/), has led to the developement of ready-to-use kits for the detection and quantification by digital PCR of key genetic alterations of brain tumours, specifically gliomas.
Dr. Emeline Tabouret (MCU-PH) and Dr. Chiara Bastiancich (Post-doc) from the GlioME team received the "Emergence" grant co-funded by the Canceropôle PACA and the Association pour la Recherche sur les Tumeurs Cérébrales (ARTC-Sud).
Dr. Tabouret wants to develop CAR-T cells directed against glioblastoma stem cells. The first step will be to design and then transfect the CARs into T cells and analyze their efficacy in vitro. The second step will consist of analyzing the in vivo efficacy of the CAR-T cells.
Le label « Plateforme Technologique Aix-Marseille » de la PlateForme NeuroTimone PFNT a été renouvelé pour une nouvelle période de 3 ans par AMU, l’Inserm et le CNRS. Pour mémoire rappelons que la PFNT est constituée des plateformes NCIS, PINT et SCeNT de l’INP et de INPHIM de l’INT. La PFNT offre un éventail de prestations technologiques en neurobiologie au niveau local pour les équipes de recherche et start up de Marseille mais aussi au niveau régional et national.
Une production théâtrale et une performance artistique qui auront lieu le 8 décembre à 19h30 (suite au confinement, la performance a été reportée pour la prochaine saison). Cette représentation, produite par Nadia Merad Coliac, est une œuvre inédite. Elle aura lieu à Paris au théatre Reine Blanche, scène des arts et des sciences. C'est la première fois qu'elle travaille pour un théâtre.
The Platform INteractome Timone - PINT is pleased to announce the arrival of a brand new Surface Plasmon Resonance Biacore T200 (Cytiva, ex GE Healthcare) designed to follow in real time interactions between free-labeled biomolecules from ions to viruses. The use of real-time measurement allows to provide association (kon) and dissociation (koff) rate constant of the interaction and to deduce its affinity (KD).
In this review, we focused on the most widely used 3D human glioblastoma models: spheroids, tumorospheres, organotypic slices, explants, tumoroids and glioblastoma-derived from cerebral organoids. We discuss their history, development and especially their usefulness.
We are very excited to announce that our project "Artificial Intelligence for Onco-Plasma" carried out by Remi Eyraud from QARMA team of LIS in collaboration with team 8, team 9, team 10, and PINT platform of INP, was awarded a grant from the MIC (Mathema
INP platform PINT together with AFMB and IMM are glad to announce their first inter-platform interactome workshop entitled "Methods to study Molecular Interactions (Biomedical applications)" that will take place from monday december 7th to friday 11th 2020.
Looking to confirm the interaction between a drug and its target?
Wanting to characterize the interaction between a receptor and its ligand?
Christophe Leterrier, leader of the NeuroCyto team, just published a special review for the 40th anniversary issue of the Journal of Neuroscience. Entitled “A Pictorial History of the Neuronal Cytoskeleton”, it is a journey through the history of the neuronal cytoskeleton in pictures.
A few weeks ago, the Vaincre Alzheimer Foundation came to visit the Institute of NeuroPhysiopathology and made a short documentary on the team Neural Plasticity and Degeneration (Team 1), led by Santiago Rivera who was recently funded by the Foundation.
Dans la semaine du lundi 07 décembre au vendredi 11 décembre s'est tenue avec succès la première édition de l'atelier MedIM (Methodes d'étude des Interactions Moléculaires) co-organisé par la Plateforme INteractome Timone (PINT) de l’INP, la plateforme de Biologie Structurale de l’AFMB et les plateformes de l’IMM, toutes trois labellisées "Plateformes Technologiques du site d'Aix-Marseille".
The NeuroCyto team led by Christophe Leterrier was awarded two collaborative ANR grants in the 2020 call. The first project, “How actin/spectrin scaffold shapes axonal physiology” (ASHA), is coordinated by C. Leterrier in collaboration with the teams of Stéphane Vassilopoulos (Institut de Myologie, Paris) and Emmanuel Nivet at INP.
Laurie Arnaud will be presenting on the Neurobinar #3 on December 17 at 4 pm on Zoom.
For this third edition, NeuroMarseille is pleased to welcome Christelle Baunez (INT), Laurie Arnaud (INP) and Nada El Mahmoudi (LNSC/LNC). Laurie Arnaud and Nada El Mahmoudi will introduce their respective theses in a cross presentation. After a question and answer session, Christelle Baunez (INT) will explain her research on the role of basal ganglia (GB) in motivation and reward processes.
This paper entitled "SCENITH: A Flow Cytometry-Based Method to Functionally Profile Energy Metabolism with Single-Cell Resolution" presents a new technique to study the metabolic responses in multiple cell types in parallel by flow cytometry.
A successful partnership between the APHM Pathology department / the GlioME team and ID-Solutions industrial society (https://www.id-solutions.fr/fr/), has led to the developement of ready-to-use kits for the detection and quantification by digital PCR of key genetic alterations of brain tumours, specifically gliomas.
The Institute of NeuroPhysiopathology (INP) is a new laboratory of the CNRS/Aix-Marseille University created in 2018 that combines fundamental and translational research in a stimulating and friendly working environment (https://inp.univ-amu.fr). The INP is located on the Health Sciences Campus of La Timone, which is home to other leading neuroscience laboratories, bringing together more than 400 people covering a wide range of topics.
Dr. Emeline Tabouret (MCU-PH) and Dr. Chiara Bastiancich (Post-doc) from the GlioME team received the "Emergence" grant co-funded by the Canceropôle PACA and the Association pour la Recherche sur les Tumeurs Cérébrales (ARTC-Sud).
Le label « Plateforme Technologique Aix-Marseille » de la PlateForme NeuroTimone PFNT a été renouvelé pour une nouvelle période de 3 ans par AMU, l’Inserm et le CNRS. Pour mémoire rappelons que la PFNT est constituée des plateformes NCIS, PINT et SCeNT de l’INP et de INPHIM de l’INT. La PFNT offre un éventail de prestations technologiques en neurobiologie au niveau local pour les équipes de recherche et start up de Marseille mais aussi au niveau régional et national.
Aix Marseille Université | All rights reserved - Legal notice
